{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:10:54Z","timestamp":1785413454512,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA041579"],"award-info":[{"award-number":["U01DA041579"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA004523"],"award-info":[{"award-number":["R01DA004523"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046081"],"award-info":[{"award-number":["R01DA046081"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007262"],"award-info":[{"award-number":["T32DA007262"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31925017"],"award-info":[{"award-number":["31925017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX003279"],"award-info":[{"award-number":["BX003279"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["15F-RCS-009"],"award-info":[{"award-number":["15F-RCS-009"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.molpha.2025.100080","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:11:59Z","timestamp":1758939119000},"page":"100080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mice carrying the human dopamine D2 receptor pathogenic mutation p.Met374Arg exhibit hyperactivity and aberrant D2 receptor function"],"prefix":"10.1016","volume":"107","author":[{"given":"Dayana","family":"Rodriguez-Contreras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2923-7103","authenticated-orcid":false,"given":"Joseph J.","family":"Lebowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8798-2347","authenticated-orcid":false,"given":"Cheryl","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4056-4353","authenticated-orcid":false,"given":"Elizabeth","family":"Walker-Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6837-9780","authenticated-orcid":false,"given":"Guochuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4966-9708","authenticated-orcid":false,"given":"Shu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9166-9919","authenticated-orcid":false,"given":"Yulong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1886-4566","authenticated-orcid":false,"given":"Lev M.","family":"Fedorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7350-6323","authenticated-orcid":false,"given":"Tamara J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0647-6144","authenticated-orcid":false,"given":"John T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0109-7345","authenticated-orcid":false,"given":"Kim A.","family":"Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.molpha.2025.100080_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.molpha.2025.100080_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/mds.28385","article-title":"A gain-of-function variant in dopamine D2 receptor and progressive chorea and dystonia phenotype","volume":"36","author":"van der Weijden","year":"2021","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.molpha.2025.100080_bib3","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/mds.28634","article-title":"Childhood-onset chorea caused by a recurrent de novo DRD2 variant","volume":"36","author":"Mencacci","year":"2021","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.molpha.2025.100080_bib4","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/mds.28635","article-title":"Reply to: \u201cChildhood onset chorea caused by a recurrent de novo DRD2 variant\u201d","volume":"36","author":"van der Weijden","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.molpha.2025.100080_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for modeling G-protein coupled receptors","volume":"25","author":"Ballesteros","year":"1995","journal-title":"Methods Neurosci"},{"key":"10.1016\/j.molpha.2025.100080_bib6","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1021\/acschemneuro.0c00712","article-title":"Signaling-biased and constitutively active dopamine D2 receptor variant","volume":"12","author":"Rodriguez-Contreras","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.molpha.2025.100080_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116228","article-title":"Comparison of the function of two novel human dopamine D2 receptor variants identifies a likely mechanism for their pathogenicity","volume":"228","author":"Rodriguez-Contreras","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molpha.2025.100080_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience"},{"issue":"5475","key":"10.1016\/j.molpha.2025.100080_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/251529a0","article-title":"Regulation of striatal acetylcholine concentration by dopamine receptors","volume":"251","author":"Sethy","year":"1974","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.molpha.2025.100080_bib10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nn769","article-title":"Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum","volume":"4","author":"Zhou","year":"2001","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.molpha.2025.100080_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/molpharm.122.000606","article-title":"Gait abnormalities and aberrant D2 receptor expression and signaling in mice carrying the human pathogenic mutation DRD2I212F","volume":"103","author":"Rodriguez-Contreras","year":"2023","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.molpha.2025.100080_bib12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nn.2862","article-title":"Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors","volume":"14","author":"Bello","year":"2011","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.1016\/j.molpha.2025.100080_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/dvg.20228","article-title":"Characterization of a mouse strain expressing Cre recombinase from the 3' untranslated region of the dopamine transporter locus","volume":"44","author":"Backman","year":"2006","journal-title":"Genesis"},{"issue":"6096","key":"10.1016\/j.molpha.2025.100080_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"W1","key":"10.1016\/j.molpha.2025.100080_bib15","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.molpha.2025.100080_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"10","key":"10.1016\/j.molpha.2025.100080_bib17","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/jnr.22699","article-title":"Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning","volume":"89","author":"Goldberg","year":"2011","journal-title":"J Neurosci Res"},{"issue":"37","key":"10.1016\/j.molpha.2025.100080_bib18","doi-asserted-by":"crossref","first-page":"11550","DOI":"10.1523\/JNEUROSCI.3307-09.2009","article-title":"Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6\/2 mouse model of Huntington's disease","volume":"29","author":"Dai","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.molpha.2025.100080_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11102","article-title":"A dystonia-like movement disorder with brain and spinal neuronal defects is caused by mutation of the mouse laminin \u03b21 subunit, Lamb1","volume":"4","author":"Liu","year":"2015","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.molpha.2025.100080_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.131","article-title":"N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6\/1 mouse model of Huntington's disease","volume":"5","author":"Wright","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.molpha.2025.100080_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuroscience.2017.07.031","article-title":"Exercise in an animal model of Parkinson's disease: Motor recovery but not restoration of the nigrostriatal pathway","volume":"359","author":"Churchill","year":"2017","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.molpha.2025.100080_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1601-183X.2004.00101.x","article-title":"Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine","volume":"4","author":"Kamens","year":"2005","journal-title":"Genes Brain Behav"},{"issue":"1","key":"10.1016\/j.molpha.2025.100080_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneumeth.2008.11.001","article-title":"Calibration of rotational acceleration for the rotarod test of rodent motor coordination","volume":"178","author":"Bohlen","year":"2009","journal-title":"J Neurosci Methods"},{"issue":"2","key":"10.1016\/j.molpha.2025.100080_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbr.2006.12.023","article-title":"Long-term evaluation of sensorimotor and mnesic behaviour following striatal NMDA-induced unilateral excitotoxic lesion in the mouse","volume":"178","author":"Haelewyn","year":"2007","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.molpha.2025.100080_bib25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41592-023-02100-w","article-title":"Improved green and red GRAB sensors for monitoring dopaminergic activity in vivo","volume":"21","author":"Zhuo","year":"2024","journal-title":"Nat Methods"},{"issue":"11","key":"10.1016\/j.molpha.2025.100080_bib26","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s41592-020-0953-2","article-title":"An optimized acetylcholine sensor for monitoring in vivo cholinergic activity","volume":"17","author":"Jing","year":"2020","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/j.molpha.2025.100080_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/mthe.2001.0246","article-title":"Combined injection of rAAV with mannitol enhances gene expression in the rat brain","volume":"3","author":"Mastakov","year":"2001","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.molpha.2025.100080_bib28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/acschemneuro.9b00675","article-title":"Photoactivatable dopamine and sulpiride to explore the function of dopaminergic neurons and circuits","volume":"11","author":"Asad","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.molpha.2025.100080_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-925X-2-13","article-title":"ScanImage: flexible software for operating laser scanning microscopes","volume":"2","author":"Pologruto","year":"2003","journal-title":"Biomed Eng Online"},{"issue":"9","key":"10.1016\/j.molpha.2025.100080_bib30","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.molpha.2025.100080_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110231","article-title":"Stride-level analysis of mouse open field behavior using deep-learning-based pose estimation","volume":"38","author":"Sheppard","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.molpha.2025.100080_bib32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0072-9752(07)01256-0","article-title":"Neuropathology of Huntington's disease","volume":"89","author":"Vonsattel","year":"2008","journal-title":"Handb Clin Neurol"},{"issue":"6587","key":"10.1016\/j.molpha.2025.100080_bib33","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1126\/science.abn0532","article-title":"An action potential initiation mechanism in distal axons for the control of dopamine release","volume":"375","author":"Liu","year":"2022","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.molpha.2025.100080_bib34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41593-025-01906-5","article-title":"An axonal brake on striatal dopamine output by cholinergic interneurons","volume":"28","author":"Zhang","year":"2025","journal-title":"Nat Neurosci"},{"issue":"21","key":"10.1016\/j.molpha.2025.100080_bib35","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/hmg\/ddl252","article-title":"Cholinergic neuronal defect without cell loss in Huntington's disease","volume":"15","author":"Smith","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"25","key":"10.1016\/j.molpha.2025.100080_bib36","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1523\/JNEUROSCI.0589-14.2014","article-title":"Multiphasic modulation of cholinergic interneurons by nigrostriatal afferents","volume":"34","author":"Straub","year":"2014","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.molpha.2025.100080_bib37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ana.98","article-title":"Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder","volume":"49","author":"Fernandez","year":"2001","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.molpha.2025.100080_bib38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.24119","article-title":"Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia","volume":"75","author":"Chen","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.molpha.2025.100080_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bcp.2019.02.005","article-title":"Functional characterization of AC5 gain-of-function variants: impact on the molecular basis of ADCY5-related dyskinesia","volume":"163","author":"Doyle","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"10.1016\/j.molpha.2025.100080_bib40","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.0000000000004262","article-title":"Movement disorder in GNAO1 encephalopathy associated with gain-of-function mutations","volume":"89","author":"Feng","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.molpha.2025.100080_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nbd.2018.05.005","article-title":"A mechanistic review on GNAO1-associated movement disorder","volume":"116","author":"Feng","year":"2018","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.molpha.2025.100080_bib42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/brainsci13050743","article-title":"Emergence of treadmill running ability and quantitative assessment of gait dynamics in young Ts65Dn mice: a mouse model for Down syndrome","volume":"13","author":"Scott-McKean","year":"2023","journal-title":"Brain Sci"},{"issue":"2\u20133","key":"10.1016\/j.molpha.2025.100080_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(89)90837-6","article-title":"Biphasic effect of D-2 agonist quinpirole on locomotion and movements","volume":"161","author":"Eilam","year":"1989","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.molpha.2025.100080_bib44","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0026-895X(24)26497-X","article-title":"The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor","volume":"57","author":"Alewijnse","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100080_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbr.2016.04.044","article-title":"High-speed video gait analysis reveals early and characteristic locomotor phenotypes in mouse models of neurodegenerative movement disorders","volume":"311","author":"Preisig","year":"2016","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.molpha.2025.100080_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00177711","article-title":"Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands","volume":"335","author":"Urwyler","year":"1987","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"10.1016\/j.molpha.2025.100080_bib47","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1208\/s12248-014-9649-9","article-title":"The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family","volume":"16","author":"Dos Santos Pereira","year":"2014","journal-title":"AAPS J"},{"issue":"9","key":"10.1016\/j.molpha.2025.100080_bib48","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1038\/s41380-018-0212-4","article-title":"Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation","volume":"25","author":"Donthamsetti","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.molpha.2025.100080_bib49","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41380-021-01364-y","article-title":"Dopamine D2 receptors modulate the cholinergic pause and inhibitory learning","volume":"27","author":"Gallo","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"17","key":"10.1016\/j.molpha.2025.100080_bib50","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.5094-09.2010","article-title":"Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder","volume":"30","author":"Bowton","year":"2010","journal-title":"J Neurosci"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2515640X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2515640X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:14:51Z","timestamp":1763979291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2515640X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0026895X2515640X"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100080","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mice carrying the human dopamine D2 receptor pathogenic mutation p.Met374Arg exhibit hyperactivity and aberrant D2 receptor function","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100080"}}